Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Window of Opportunity Study to Evaluate the Role of the Combination of Metformin and Simvastatin as a Neoadjuvant Therapy in Invasive Bladder Cancer

NCT02360618 is registered in ClinicalTrials.gov with London Health Sciences Centre as lead sponsor.

NCT NCT02360618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02360618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Window of Opportunity Study to Evaluate the Role of the Combination of Metformin and Simvastatin as a Neoadjuvant Therapy in Invasive Bladder Cancer
Lead sponsor
London Health Sciences Centre
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2015
Completion date
January 31, 2018
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer